The Economic Impact of the T2Candida® Panel
Download a the study published in Future Microbiology demonstrating that in a 500-bed hospital with an average of 5,100 symptomatic patients at high risk for developing a Candida infection, early detection with the utilization of the T2Candida Panel could provide an annual cost savings of approximately $5.8 million and the prevention of 60 percent of Candida-related deaths.
